Corporate Responsibility
Leading with our Values
We are committed to operating responsibly, conserving resources and meeting all environmental requirements that apply to us. As a Company, we are also committed to making our workplaces safe and secure.
Corporate Governance
Committed to Integrity
We measure our success not only by our achievements but by our adherence to the highest standards of accountability in everything we do.
Haemonetics Leadership
Purpose, passion, performance
Our leadership team sets the example for how we make it matter every day by living our Values: Think Big, Take Action, Win Together, and Always Learn and Improve.
Our History
1968
The Latham Bowl Is Invented
1971
Haemonetics Is founded
1974
Cell Saver® System Is Introduced
1981
Haemonetics Opens Its First International Headquarters
1984
PCS® Plasma Collection System Launches
1991
A public company
The company is taken public again, successfully completing an initial public offering (HAE) on the New York Stock Exchange.
1992
MCS® Mobile Apheresis System Launches, Making Blood Component Therapy Possible At Blood Banks
1993
PCS® 2 Launches, Introducing Blow-Molded Plasma Collection Bowl
1995
MCS®+ Mobile Platelet Collection System Launches
2003
ACP® 215 System Cell Washing Protocol Is Introduced
2008
Haemonetics Acquires TEG® 5000 Hemostasis Analyzer
2009
Haemonetics Invests in Information Management & Technology
2010
BloodTrack® & SafeTrace Tx® Systems Added to the Hospital Portfolio
2011
Cell Saver® Elite® System Launches
2015
BloodTrack® HaemoBank® Blood Management System Is Introduced
2015
TEG® 6s Analyzer And TEG Manager® Software Are Introduced
2017
Cell Saver® Elite®+ System Launches
2017
NexSys PCS® Plasma Collection System Launches
2018
NexLynk DMS® Software Launches
2018
YES® Technology For NexSys PCS® Receives FDA 510(k) Clearance
2019
Haemonetics Releases New SafeTrace Tx® Transfusion Management Software
2019
Haemonetics Opens New HQ in Boston
2020
The NexSys PCS® System With Persona® Technology Launches
2021
Haemonetics Acquires the VASCADE® Product Family
2022
Haemonetics Opens New Center of Excellence in Clinton, PA
2022
Haemonetics Earns MDR CE Mark for VASCADE® Portfolio
2023
Haemonetics Earns Approval in Japan for VASCADE MVP®
2023
Haemonetics Launches Cell Saver® Elite® + with Intelligent Control
2023
Haemonetics Earns FDA Clearance for New Plasma Collection Bowl and Express® Plus Software for the NexSys PCS® Plasma Collection Device
2023
Haemonetics Acquires OpSens Inc. and the SavvyWire® Pre-Shaped Pressure Guidewire and the OptoWire® Pressure Guidewire Technologies
2024
Haemonetics Acquires Attune Medical and the ensoETM® Proactive Esophageal Cooling Device
2024
Haemonetics launches TEG® 6s Global Hemostasis - HN cartridge in the U.S.
2024
Haemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire
2024